Capricor Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Duchenne Muscular Dystrophy Therapy
February 05, 2018 11:11 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) today announced that the U.S. Food and Drug Administration (FDA) has granted CAP-1002, its lead investigational...
Capricor Announces Licensing of Additional Patent Applications from Cedars-Sinai Medical Center for Cellular and Exosome-based Technologies
January 16, 2018 07:00 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) announced today that it has added seven new patent applications to its existing Exclusive License Agreements with...
![Cellular Dynamics International, Inc. logo](/news-release/logo/319994/0/319994.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A09&size=2)
Cellular Dynamics and Northwestern University Take First Steps Toward Rebuilding an Organ Using Manufactured Human Cells
November 18, 2014 08:00 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced the publication1 of a study in the American Journal of Transplantation describing a...
Scott Carmer Named as CEO of Orgenesis North America
August 04, 2014 09:00 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 4, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of...